Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy
Adolfo Etchegaray(Nationwide Children's Hospital), Bimal P. Chaudhari(Nationwide Children's Hospital), Oluyinka O. Olutoye, Oluseyi Ogunleye(Nationwide Children's Hospital), Amy Schlegel(Nationwide Children's Hospital), Darrah Haffner(Nationwide Children's Hospital), Stephanie M. Cruz(Nationwide Children's Hospital), Jason Xia(Nationwide Children's Hospital)
Cited by 2
Related Papers
Chronic wounds: Treatment consensus
|Wound Repair and Regeneration|2022|368
Fetoscopic Open Neural Tube Defect Repair
|Obstetrics and Gynecology|2017|325
Relaxin confers cytotrophoblast protection from hypoxia-reoxygenation injury through the phosphatidylinositol 3-kinase-Akt/protein kinase B cell survival pathway
|American Journal of Physiology-Regulatory, Integrative and Comparative Physiology|2017|18
Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes
|The Journal of Maternal-Fetal & Neonatal Medicine|2016|16
Fetal interventional procedures and surgeries: a practical approach
|Journal of Perinatal Medicine|2017|15